Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 4
2020 1
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Advanced analytical methodologies in Alzheimer's disease drug discovery.
De Simone A, Naldi M, Tedesco D, Bartolini M, Davani L, Andrisano V. De Simone A, et al. Among authors: davani l. J Pharm Biomed Anal. 2020 Jan 30;178:112899. doi: 10.1016/j.jpba.2019.112899. Epub 2019 Sep 29. J Pharm Biomed Anal. 2020. PMID: 31606562 Free article. Review.
Aβ1-42 peptide toxicity on neuronal cells: A lipidomic study.
Davani L, Fu X, De Simone A, Li P, Montanari S, Lämmerhofer M, Andrisano V. Davani L, et al. J Pharm Biomed Anal. 2022 Sep 20;219:114876. doi: 10.1016/j.jpba.2022.114876. Epub 2022 Jun 6. J Pharm Biomed Anal. 2022. PMID: 35749963
Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
Hulcová D, Breiterová K, Siatka T, Klímová K, Davani L, Šafratová M, Hošťálková A, De Simone A, Andrisano V, Cahlíková L. Hulcová D, et al. Among authors: davani l. Molecules. 2018 Mar 21;23(4):719. doi: 10.3390/molecules23040719. Molecules. 2018. PMID: 29561817 Free PMC article.
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.
De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A. De Simone A, et al. Among authors: davani l. ACS Med Chem Lett. 2019 Feb 4;10(4):469-474. doi: 10.1021/acsmedchemlett.8b00507. eCollection 2019 Apr 11. ACS Med Chem Lett. 2019. PMID: 30996781 Free PMC article.
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease".
De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A. De Simone A, et al. Among authors: davani l. ACS Med Chem Lett. 2019 Aug 6;10(9):1357. doi: 10.1021/acsmedchemlett.9b00316. eCollection 2019 Sep 12. ACS Med Chem Lett. 2019. PMID: 31531210 Free PMC article.